Bristol-Myers Squibb Announces Specialty Pharmacy Patient Management Programs For Sprycel® (dasatinib) Patients

Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. today announced the launch of patient management programs for Sprycel® patients with a select group of specialty pharmacy providers.

Powered by WPeMatico